NCT04778735CompletedNot Applicable
Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation: A Retrospective Study
Memorial Bahçelievler Hospital2 sites in 1 country207 target enrollmentStarted: February 24, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 207
- Locations
- 2
- Primary Endpoint
- Survival
Study Overview
Brief Summary
The Department of Organ Transplantation in Memorial Hospitals has started Pediatric Liver Transplantation Program in 2016. As of the end of 2020, we have performed 169 pediatric liver transplantation. The aim of this study is to investigate the overall mortality, morbidity and risk factors for adverse outcomes in pediatric liver transplantation. The patients' records will be retrospectively scanned and the data will be gathered.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 0 Months to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Pediatric patients with liver transplantation (<18 years)
Exclusion Criteria
- •Patients with incomplete medical records will be excluded
Outcomes
Primary Outcomes
Survival
Time Frame: 1 minutes
Patient and graft survival ratios
Secondary Outcomes
- Perioperative informations(5 minutes)
- Postoperative Complications(5 minutes)
- Postoperative informations(10 minutes)
- Blood Tests(15 minutes)
Investigators
Kamil Yalçın Polat
Prof.Dr.
Memorial Bahçelievler Hospital
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Pediatric Liver DatabaseLiver TransplantLiver DiseaseNCT00677625Medical College of Wisconsin401
Unknown
Not Applicable
Complications of Pediatric Liver TransplantationLiver Transplant ComplicationsNCT04104971Assiut University45
Recruiting
Not Applicable
Living Donor Liver Transplant for Unresectable Colorectal Liver MetastasesColorectal Cancer MetastaticNCT05248581University of Rochester25
Completed
Phase 3
Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative SteroidsLiver TransplantationInfectionNCT00149890Novartis77
Recruiting
Not Applicable
Design and Implementation of the Pediatric Liver Transplantation BiobankLiver DiseasesPediatric ALLLiver Transplant ComplicationsNCT04477967Children's Hospital of Chongqing Medical University500